+794.9%
MRNA vs RF
+18.9%
+776.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +1.2% | -4.7% | -2.5% |
| 7D | -12.1% | +1.9% | -14.1% | -10.8% |
| 30D | -1.3% | +7.3% | -8.6% | +5.0% |
| 3M | +250.9% | -7.9% | +258.9% | +229.6% |
| 6M | +343.0% | +10.5% | +332.5% | +280.5% |
| YTD | +657.4% | +9.6% | +647.8% | +500.2% |
| 1Y | +794.9% | +20.3% | +774.6% | +557.8% |
| All | +794.9% | +18.9% | +776.0% | +557.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RF.
Daily Out/Under-Performance
Portfolio return minus RF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling